4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
NCT05197270
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
215
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular (Wet) Age-Related Macular Degeneration
Interventions
BIOLOGICAL:
4D-150 IVT
BIOLOGICAL:
Aflibercept IVT
Sponsor
4D Molecular Therapeutics